About AIC

Arthritis Innovation Corporation (AIC) develops innovative solutions to address unmet needs in Orthopedic Surgery and Arthritis management. A private company founded in 2013, AIC is partnered with MedinCell (www.medincell.com), and leverages a world-class product development team in Toronto, Canada with MedinCell's proprietary polymer platform technology. The Company's first product under aggressive development is intended for the management of pain and inflammation following total knee replacement (TKR) through sustained local delivery of a marketed NSAID, as an alternative to oral NSAIDs or narcotics.